StandardStandard

All Wales Medicines Strategy Group Final Appraisal Report - Anidulafungin (Ecalta) for the treatment of invasive candidiasis in adult non-neutropenic patients. / Hughes, D.; Hughes, D.A.; All Wales Strategy Group., [No Value].
2009 gol. Unknown, 2009.

Allbwn ymchwil: Llyfr/AdroddiadAdroddiad Comisiwn

HarvardHarvard

APA

CBE

MLA

VancouverVancouver

Author

RIS

TY - BOOK

T1 - All Wales Medicines Strategy Group Final Appraisal Report - Anidulafungin (Ecalta) for the treatment of invasive candidiasis in adult non-neutropenic patients.

AU - Hughes, D.

AU - Hughes, D.A.

AU - All Wales Strategy Group., [No Value]

PY - 2009/1/1

Y1 - 2009/1/1

UR - http://www.wales.nhs.uk/sites3/Documents/371/Anidulafungin%20(Ecalta)%20FAR%20website.pdf

M3 - Commissioned report

BT - All Wales Medicines Strategy Group Final Appraisal Report - Anidulafungin (Ecalta) for the treatment of invasive candidiasis in adult non-neutropenic patients.

PB - Unknown

ER -